This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
AUA 2020
AUA 2020
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular and Penile Cancer
Bladder Health
BPH and Lower Urinary Tract Infections
COVID-19 and Genitourinary Cancers
Press Releases
AUA 2020 Prostate Cancer
Viewing 21-40 of 54 articles
AUA 2020: Development of a Whole-Urine, Multiplexed, Next Generation RNA-Sequencing Assay for Aggressive Prostate Cancer Early Detection
AUA 2020: Androgen Deprivation Therapy (ADT): Reducing Morbidity and Improving Outcome
AUA 2020: Feasibility and Accuracy of Transperineal Free-Hand mpMRITargeted Prostate Biopsies Under Local Anesthesia: A Multicenter Prospective Cohort of 1,014 Patients
AUA 2020: Detection Of Germline Mutations in Localized and Metastatic Prostate Cancer Through Guideline-Based Testing
AUA 2020: Which Prostate Cancers are Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from PROMIS
AUA 2020: Automated Performance Metrics to Predict Continence Recovery After Robotic Radical Prostatectomy Utilizing Machine Learning
AUA 2020: Patient Experience for Transperineal Biopsy Under Local Anesthesia Versus Transrectal Biopsy: Results from the Michigan Urological Surgery Improvement Collaborative
AUA 2020: Radical Prostatectomy for Patients with High-Risk, Very-High Risk, or Metastatic Prostate Cancer: Oncologic Results from the MUSIC Statewide Collaborative
AUA 2020: Panel Discussion: Genetic Testing: What the Urologist Needs to Know
AUA 2020: The Role of BMI on Hospital Readmission after Minimally-Invasive Radical Prostatectomy
AUA 2020: The Rapid Access Prostate Imaging and Diagnosis (RAPID) Pathway – A Multicenter Update of 1719 Patients Undergoing Multiparametric MRI as a Triage Test
AUA 2020: Incidence of Metachronous Contralateral Testicular Cancer and Association with Chemotherapy
AUA 2020: Journal of Urology Lecture: Use of Web and Social Media Sources for Physician Education
AUA 2020: Reviewing the Current Indispensable Role of Prostate MRI
AUA 2020: Why Precision Matters: Implications of Genomic Analysis for mCRPC
AUA 2020: Comparison of Different Biopsy Schedules Among Men On Active Surveillance: Analysis of the GAP3 Global Consortium Database
AUA 2020: Evaluating The Outcomes of Active Surveillance in Gleason Grade Group 2 Prostate Cancer: Prospective Results From the Canary-PASS Cohort
AUA 2020: PSMA Radioligand Therapy: A New Modality Approaches
AUA 2020: Crossfire: Controversies in Urology: Prostate Cancer Active Surveillance Can Be Done with mpMRI and Biomarkers; Biopsies are No Longer Necessary
AUA 2020: Impact of Positive Surgical Margin Length and Gleason Grade at the Margin on Oncologic Outcomes in Patients with Non-Organ-Confined Prostate Cancer
1
2
3
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free